Insights
Video
An in-depth panel discussion on the evolution of clinical trial site organizations into Patient Access Organizations (PAOs), and their growing influence in clinical research. Watch as our expert panelists share their insights on the challenges, opportunities, and future trends shaping the PAO landscape.
Watch Now
Deal Insights
Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities
Anju Software Acquired by Valsoft Corporation to Grow eClinical and Commercialization Capabilities
Learn More
BlueBook
Pharma Services July 2024
Highlights from this edition: BridgeView Life Sciences was acquired by Zensar Technologies, Exima Research Network, LLC announced its acquisition of Tidewater Clinical Research, Inc., Huma Therapeutics closed a $80MM Series A Financing, led by AstraZenca PLC (LSE:AZN), HAT SGR SpA, Leaps by Bayer, Hitachi Ventures GmbH
Download Now
BlueBook
Diagnostics and Tools July 2024
Highlights from this edition: Eurobio Scientific was acquired by MBK Partners, Astorg announced its acquisition of Hamilton Thorne, CytoReason closed a $80MM Series A Financing, led by NVDIA Corporation, Thermo Fisher Scientific, Pfizer Inc, OurCrowd Ltd
Download Now
Whitepaper
Patient Access Organizations - An Emerging Ecosystem
Welcome to the future of clinical trials, where traditional research sites are evolving into sophisticated Patient Access Organizations (PAOs). Our latest whitepaper, "Patient Access Organizations - An Emerging Ecosystem," dives deep into this transformation, offering exclusive insights and strategic opportunities for industry leaders.
Learn More
Deal Insights
Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network
Pinnacle Clinical Research Acquired The Cognitive and Research Center of New Jersey to Expand Clinical Trial Site Network
Learn More
/
6
Load More
Gain Insight Into The Health
Sciences Industries
Sign up to receive the the latest reports, research, BlueBooks, and more from the Crosstree team.